CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 178 enrolled
Drug / intervention
White Blood Cell Transfusionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00968838
NCT00968838Phase 3Completed
CompareCT.gov

Comparative Study of Radiated and Unradiated Leukocyte Transfusions for Patients With Life-threatening Infections: A Collaborative Study by the Leukemia Department and Laboratory Medicine

M.D. Anderson Cancer Center·interventional·Posted Aug 31, 2009·Updated Nov 26, 2013

In Brief

A Phase 3 clinical trial evaluating White Blood Cell Transfusion for Leukemia. Completed, enrolled 178 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to compare the effectiveness of a white blood cell transfusion with radiated cells to a white blood cell transfusion with cells that have not been radiated. The safety of this procedure will also be studied.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeukemia
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 31, 2009
Enrollment StartApr 1, 2009
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 16.8 years ago

Interventions

White Blood Cell Transfusionprocedure

4 Transfusions, each taking approximately 1 hour: Patients \<50 years of age receive 4 standard transfusions before they are randomized to receive further radiated or non radiated transfusions. Patients \>50 years of age are randomized to receive either radiated or non radiated transfusions.